| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TSNAX-DISC1 readthrough (NMD candidate) | 0.729 | 0.154 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
expanded repeat domain, CAG/CTG 1 | 0.736 | 0.154 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 1998 | 1998 | |||||||||
|
disrupted in schizophrenia 2 | 0.716 | 0.192 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2001 | 2004 | |||||||||
|
translin associated factor X | 0.760 | 0.192 | 0.49 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
5-hydroxytryptamine receptor 5A | 0.716 | 0.231 | 6.3E-03 |
|
group | 0.330 | None | 0.333 | 3 | 0 | 2000 | 2010 | ||||||||
|
potassium channel tetramerization domain containing 12 | 0.780 | 0.231 | 6.2E-02 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
SERTA domain containing 1 | 0.729 | 0.231 | 0.32 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4 | 0.617 | 0.269 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
TBC1 domain family member 25 | 0.805 | 0.269 | 0.52 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
phosphofructokinase, liver type | 0.722 | 0.269 | 2.7E-17 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
hes family bHLH transcription factor 6 | 0.686 | 0.308 | 8.4E-02 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
D-amino acid oxidase activator | 0.678 | 0.346 | 1.4E-04 |
|
group | 0.330 | None | 0.800 | 5 | 0 | 2006 | 2011 | ||||||||
|
adrenoceptor alpha 2C | 0.682 | 0.346 | 0.50 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
arginine vasopressin receptor 1B | 0.705 | 0.385 | 3.7E-04 |
|
group | 0.330 | None | 1.000 | 4 | 0 | 2004 | 2013 | ||||||||
|
inositol monophosphatase 2 | 0.695 | 0.385 | 1.1E-03 |
|
group | 0.320 | None | 0.500 | 2 | 0 | 2001 | 2007 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha5 | 0.621 | 0.385 | 0.91 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha6 | 0.678 | 0.423 | 1.3E-12 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
oxytocin/neurophysin I prepropeptide | 0.615 | 0.423 | 0.71 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
somatostatin receptor 3 | 0.659 | 0.423 | 9.9E-05 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
G protein-coupled receptor 50 | 0.686 | 0.462 | 0.65 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 2005 | 2012 | ||||||||
|
adenylate cyclase 7 | 0.656 | 0.462 | 9.5E-07 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
5-hydroxytryptamine receptor 6 | 0.626 | 0.500 | 1.9E-04 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 1999 | 2010 | ||||||||
|
corticotropin releasing hormone binding protein | 0.659 | 0.500 | 0.21 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2007 | 2007 | ||||||||
|
melanin concentrating hormone receptor 1 | 0.650 | 0.500 | 4.7E-05 |
|
group | 0.330 | None | 1.000 | 2 | 0 | 2006 | 2009 | ||||||||
|
RNA binding protein with serine rich domain 1 | 0.722 | 0.500 | 0.98 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 |